Observational analysis reveals high complication rates and substantial healthcare costs in sickle cell disease patients receiving frequent transfusions, highlighting the urgent need for novel...
Despite utilizing available care with frequent RBCTs, patients with SCD experienced a variety of disease and transfusion-related complications, including frequent VOCs and iron overload, which led to substantial HCRU and costs. These findings highlight the need for novel therapies for this patient group.
No takes yet. Share an insight, caveat, or question.
Udeze et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: